Resection margins and R1 rates in pancreatic cancer - Are we there yet?

Histopathology

Volumn 52, Issue 7, 2008, Pages 787-796

  Verbeke, C S ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Cancer; Pancreas; Pathology; Resection margin

Indexed keywords

CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; DISSECTION; HISTOPATHOLOGY; HUMAN; MICROSCOPY; OUTCOME ASSESSMENT; PANCREAS CANCER; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SUPERIOR MESENTERIC VEIN; TISSUE SECTION; TISSUE SLICE;

CARCINOMA, PANCREATIC DUCTAL; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROGNOSIS;

EID: 44249107321     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02935.x     Document Type: Review

References (67)

1. Carpelan-Holmström M, Nordling S, Pukkala E et al. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 2005 54 385 387.
2. Alexakis N, Halloran C, Raraty M, Ghaneh P, Sutton R, Neoptoleomos JP. Current standards of surgery for pancreatic cancer. Br. J. Surg. 2004 91 1410 1427.
3. Allema JH, Reinders ME, van Gulik TM et al. Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer 1995 75 2069 2076.
4. Yeo CJ, Cameron JL, Sohn TA et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann. Surg. 1997 226 248 260.
5. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Büchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br. J. Surg. 2004 91 586 594.
6. Neoptolemos JP, Stocken DD, Dunn JA et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann. Surg. 2001 234 758 768.
7. Matsuno S, Egawa S, Unno M. R0 resection for ductal pancreatic cancer - Japanese experience. Am. J. Surg. 2007 194 S110 S114.
8. Willett CG, Lewandrowski K, Warshaw AL, Efird J, Compton CC. Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann. Surg. 1993 217 144 148.
9. Yeo CJ, Cameron JL, Lillemoe KD et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann. Surg. 1995 221 721 731.
10. Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann. Surg. 1995 221 59 66.
11. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. Survival after resection for ductal adenocarcinoma of the pancreas. Br. J. Surg. 1996 83 625 631.
12. Nishimura Y, Hosotani R, Shibamoto Y et al. External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complications. Int. J. Radiat. Oncol. Biol. Phys. 1997 39 39 49.
13. Millikan KW, Deziel DJ, Silverstein JC et al. Prognostic factors associated with respectable adenocarcinoma of the head of the pancreas. Am. Surg. 1999 65 618 623.
14. Benassai G, Mastrorilli M, Quarto G, Cappiello A, Giani U, Mosella G. Survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Chir. Ital. 2000 52 263 270.
15. Sohn TA, Yeo CJ, Cameron JL et al. Resected adenocarcinoma of the pancreas - 616 patients: results, outcomes, and prognostic indicators. J. Gastrointest. Surg. 2000 4 567 579.
16. Pingpank JF, Hoffman JP, Ross EA et al. Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. J. Gastrointest. Surg. 2001 5 121 130.
17. Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A. Redefining the R1 resection in pancreatic cancer. Br. J. Surg. 2006 93 1232 1237.
18. Raut CP, Tseng JF, Sun CC et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann. Surg. 2007 246 52 60.
19. Adam IJ, Mohamdee MO, Martin IG et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994 344 707 711.
20. Birbeck KF, Macklin CP, Tiffin NJ et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann. Surg. 2002 235 449 457.
21. Dexter SPL, Sue-Ling H, McMahon MJ, Quirke P, Mapstone N, Martin IG. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer. Gut 2001 48 667 670.
22. Khan OA, Fitzgerald JJ, Soomro I, Beggs FD, Morgan WE, Duffy JP. Prognostic significance of circumferential resection margin involvement following oesophagectomy for cancer. Br. J. Cancer 2003 88 1549 1552.
23. Ujiki MB, Talamonti MS. Guidelines for the surgical management of pancreatic adenocarcinoma. Semin. Oncol. 2007 34 311 320.
24. Compton CC, Henson DE. Protocol for the examination of specimens removed from patients with carcinoma of the exocrine pancreas: a basis for checklists. Cancer Committee, College of American Pathologists. Arch. Pathol. Lab. Med. 1997 121 1129 1136.
25. Lüttges J, Vogel I, Menke M, Henne-Bruns D, Kremer B, Klöppel G. The retroperitoneal resection margin and vessel involvement are important factors determining survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Virchows Arch. 1998 433 237 242.
26. Chatelain D, Fléjou JF. Pancreatectomy for adenocarcinoma: prognostic factors, recommendations for pathological reports. Ann. Pathol. 2002 22 422 431.
27. Tsuchiya R, Noda T, Harada N et al. Collective review of small carcinomas of the pancreas. Ann. Surg. 1986 203 77 81.
28. Nagakawa T, Nagamori M, Futakami F et al. Results of extensive surgery for pancreatic carcinoma. Cancer 1996 77 640 645.
29. The Royal College of Pathologists. Standards and minimum datasets for reporting cancers. Minimum dataset for the histopathological reporting of pancreatic, ampulla of Vater and bile duct carcinoma. London : The Royal College of Pathologists, 2002.
30. Japan Pancreas Society. Classification of pancreatic cancer, 2nd edn. (English) Tokyo : Kanehara, 2003.
31. Hruban RH, Bishop Pitman M, Klimstra DS. Tumors of the pancreas. Atlas of tumor pathology, 4th Series, Fascicle 6. Washington, DC : Armed Forces Institute of Pathology, 2007.
32. Staley CA, Cleary KR, Abbruzzese JL et al. The need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas 1996 4 373 380.
33. Khalifa MA. Intraoperative assessment of the Whipple resection specimen. J. Clin. Pathol. 2007 60 975 980.
34. Khalifa MA, Maskymov V, Corwyn H, Rowsell H, Hanna S. A novel approach to the intraoperative assessment of the uncinate margin of the pancreaticoduodenectomy specimen. HPB 2007 9 146 149.
35. Nagtegaal ID, Corrie A, Marijnen M, Klein Kranenbarg E, van de Velde CJH, van Krieken JHJM. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma. Not one millimeter but two millimeters is the limit. Am. J. Surg. Pathol. 2002 26 350 357.
36. Wibe A, Rendedal PR, Svensson E et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br. J. Surg. 2002 89 327 334.
37. Sobin LH, Wittekind C (eds). International Union Against Cancer TNM classification of malignant tumours, 6th edn. New York, NY : Wiley-Liss, 2002.
38. The Royal College of Radiologists. Recommendations for cross-sectional imaging in cancer management: computed tomography - CT, magnetic resonance imaging - MRI, positron emission tomography - PET-CT. London : The Royal College of Radiologists, 2006.
39. Lüttges J, Zamboni G, Klöppel G. Recommendation for the examination of pancreaticoduodenectomy specimens removed from patients with carcinoma of the exocrine pancreas. A proposal for a standardized pathological staging of pancreaticoduodenectomy specimens including a checklist. Dig. Surg. 1999 16 291 296.
40. Albores-Saavedra J, Heffess C, Hruban RH, Klimstra D, Longnecker D. Recommendations for the reporting of pancreatic specimens containing malignant tumours. The Association of Directors of Anatomic and Surgical Pathology. Am. J. Clin. Pathol. 1999 11 304 307.
41. Nagakawa T, Sanada H, Inagaki M et al. Long-term survivors after resection of carcinoma of the head of the pancreas: significance of histologically curative resection. J. Hepatobiliary Pancreat. Surg. 2004 11 402 408.
42. Kuhlmann KF, de Castro SM, Wesseling JG et al. Surgical treatment of pancreatic adenocarcinoma: actual survival and prognostic factors in 343 patients. Eur. J. Cancer 2004 40 549 558.
43. Murtaugh LC, Leach SD. A case of mistaken identity? Nonductal origins of pancreatic 'ductal' cancers Cancer Cell 2007 11 211 213.
44. Ohigashi H, Ishikawa O, Sasaki Y et al. K-ras point mutation in the nerve plexuses around the superior mesenteric artery in resectable adenocarcinoma of the pancreatic head. Arch. Surg. 2000 135 1450 1455.
45. Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 1993 72 2118 2233.
46. Westerdahl J, Andren-Sandberg A, Ihse I. Recurrence of exocrine pancreatic cancer: local or hepatic? Hepatogastroenterology 1993 40 384 387.
47. Takai S, Satoi S, Toyokawa H et al. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience. Pancreas 2003 26 243 249.
48. Tseng JF, Raut CP, Lee JE et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J. Gastrointest. Surg. 2004 8 935 949.
49. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am. J. Surg. 1993 165 68 73.
50. Esposito I. Oral presentation at the 7th Congress of the European Hepato-Pancreato-Biliary Association. Verona, Italy, 6 June 2007.
51. Kim J, Reber HA, Dry SM et al. Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins. Gut 2006 55 1598 1605.
52. Scoggings CR, Lee JE, Evans DB. Pancreaticoduodenectomy with en bloc vascular resection and reconstruction for localized carcinoma of the pancreas. In von Hoff DD, Evans DB, Hruban RH eds. Pancreatic cancer. Sudbury, MA : Jones and Bartlett, 2005 321 334.
53. Yen T, Abdalla E, Pisters PWT et al. Pancreaticoduodenectomy. In von Hoff DD, Evans DB, Hruban RH eds. Panceatic cancer. Sudbury, MA : Jones and Bartlett, 2005.
54. Sasson AR, Hoffman JP, Ross EA, Kagan SA, Pingpank JF, Eisenberg BL. En bloc resection for locally advanced cancer of the pancreas: is it worthwhile? J. Gastrointest. Surg. 2002 6 147 158.
55. Jarufe NP, Coldham C, Mayer AD, Mirza DF, Buckels JAC, Bramhall SR. Favourable prognostic factors in a large UK experience of adenocarcinoma of the head of the pancreas and periampullary region. Dig. Surg. 2004 21 202 209.
56. Katz MHG, Bouvet M, Al-Refaie W, Gilpin EA, Moossa AR. Non-pancreatic periampullary adenocarcinomas: an explanation for favorable prognosis. Hepatogastroenterology 2004 51 842 846.
57. Schmidt CM, Powell ES, Yiannoutsos CT et al. Pancreaticoduodenectomy. A 20-year experience in 516 patients. Arch. Surg. 2004 139 718 727.
58. Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann. Surg. 1998 227 821 831.
59. Monson JRT, Donohue JH, McEntee GP et al. Radical resection for carcinoma of the ampulla of Vater. Arch. Surg. 1991 126 353 357.
60. Van Geenen RCI, van Gulik TM, Offerhaus GJA et al. Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update. EJSO 2001 27 549 557.
61. Kayahara M, Nagakawa T, Ohta T, Kitagawa H, Miyazaki I. Surgical strategy for carcinoma of the papilla of Vater on the basis of lymphatic spread and mode of recurrence. Surgery 1997 121 611 617.
62. De Castro SMM, van Heek NT, Kuhlmann KFD et al. Surgical management of neoplasms of the ampulla of Vater: local resection or pancreatoduodenectomy and prognostic factors for survival. Surgery 2004 136 994 1002.
63. Chiche L, Alkoffer B, Parienti JJ et al. Usefulness of follow-up after pancreatoduodenectomy for carcinoma of the ampulla of Vater. HPB 2007 9 140 145.
64. Nagtegaal ID, van de Velde CJH, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH, Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J. Clin. Oncol. 2002 20 1729 1734.
65. Beger HG, Treitschke F, Gansauge F, Harada N, Hiki N, Mattfeldt T. Tumor of the ampulla of Vater. Experience with local or radical resection in 171 consecutively treated patients. Arch. Surg. 1999 134 526 532.
66. Todoroki T, Koike N, Morishita Y et al. Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Ann. Surg. Oncol. 2003 10 1176 1183.
67. Scheunemann P, Stoecklein NH, Rehders A et al. Frequency and prognostic significance of occult tumor cells in lymph nodes in patients with adenocarcinoma of the papilla of Vater. HPB 2007 9 135 139.